Sensus Healthcare, Inc. (NASDAQ:SRTS)

Sunday, August 11, 2024, 11:21 AM
Meet Sam McColgan, A New Full-Time Microcap Investor We’re Predicting Great Things From [GeoWire Weekly No. 148]
Sunday, July 28, 2024, 8:19 AM
Richard Simmons Wouldn’t Be Happy with GLP-1 Weight Loss Treatment, But We Might Be [GeoWire Weekly No. 146]
Sunday, May 12, 2024, 2:30 PM
Stock Selling Near Tangible Book Value With 47% To 200% Upside [GeoWire Weekly No. 135]
See All GeoWire Weekly...

Sensus Healthcare, Inc. manufactures and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides Sentinel service program, which offers its customers protection for their SRT-100 and SRT-100 Vision systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was founded in 2010 and is headquartered in Boca Raton, Florida.

Last updated September 20, 2018


Market Data powered by QuoteMedia. Terms of Use